English | Español
Mifeed | Apr 27, 2023

Jazz Pharmaceuticals to Report 2023 First Quarter Financial Results on May 10, 2023
Patient Daily | Apr 27, 2023

Intra-Cellular Therapies to Host First Quarter 2023 Financial Results Conference Call and Webcast
Patient Daily | Apr 27, 2023

Digital therapeutics: at an inflection point
Patient Daily | Apr 27, 2023

Exagen to Announce First Quarter 2023 Financial Results on May 15, 2023
Patient Daily | Apr 27, 2023

Clinical ink Announces New Continuous Glucose Monitoring Solution
Patient Daily | Apr 27, 2023

Augmedix Secures Strategic Financing from HCA Healthcare and Redmile Group
Patient Daily | Apr 27, 2023

Augmedix Announces Partnership with HCA Healthcare to Accelerate the Development of AI-enabled Ambient Documentation
Patient Daily | Apr 27, 2023

Bristol Myers Squibb Strengthens Cell Therapy Capabilities by Adding New U.S. Manufacturing Facility for Viral Vector Production

Trending
Patient Daily | Nov 5, 2025

Pacific Research Institute CEO on misuse of 340B funds: ‘340B was meant to help low-income patients'
+ Pharmaceuticals
Patient Daily | Nov 6, 2025

Mark Cuban on PBMs: ‘Patients are getting ripped off because PBMs and wholesalers insist on using inflated list prices'
+ Pharmaceuticals
Patient Daily | Nov 3, 2025

Patient groups urge Congress to renew enhanced premium tax credits before open enrollment
Patient Daily | Nov 5, 2025

Riley Gaines on 340B program: ‘Blue states are using taxpayer dollars to fund unregulated child mutilation procedures’